MediMusic Real World Validation
Research type
Research Study
Full title
MediMusic real world validation for pain and medication self-management in patients with chronic musculoskeletal conditions
IRAS ID
324413
Contact name
Katherine A. Finlay
Contact email
Sponsor organisation
Lancashire Teaching Hospitals NHS Foundation Trust
Duration of Study in the UK
0 years, 5 months, 28 days
Research summary
Context: The medicinal effect of music for both acute and chronic pain has long been recognised through its impact on heart rate, respiratory rate, and blood pressure, via a range of musical features such as tempo, tonality, harmony, timbre, rhythm, and listeners preference . Those with chronic pain in particular may benefit from the use of medicinal music due to the requirement for pain management. Over the financial year 2021/22, over £151 million was spent on prescription medication for musculoskeletal and joint diseases in England (NHS BSA, 2022). The study aims to improve quality of life for people with chronic musculoskeletal conditions (including osteoarthritis), allowing them to self-manage their pain and any related distress. This will be done via a 'MediMusic' device used in their own homes during a one-month period of daily music listening, tailored to the individual.
Methods: The study is a repeated-measure within-subjects design spanning a 28 day period, and will recruit 50 participants from the complex chronic pain service at Lancashire Teaching Hospitals NHS Foundation Trust. Participants will be recruited via letter/patient information sheet and invited to attend an outpatient research pain clinic, at which they would then be consented. Participants will receive a daily MediMusic intervention consisting of a music playlist lasting approximately 20-25 minutes for 28 days. A range of measures will be taken at baseline and daily/weekly intervals, including the Quality of life scale/questionnaire, and pre- and post-tests taking approximately 7 minutes combined. Biofeedback will be gathered via a smart watch with step count. A feedback interview to assess the intervention will occur at then end of the trial.Anticipated Outcomes: It is anticipated that the impact of this research will not only improve pain management for those with musculoskeletal conditions, but also offer a strategy to self-manage pain through using a non-pharmaceutical intervention.
REC name
London - Brighton & Sussex Research Ethics Committee
REC reference
23/LO/0314
Date of REC Opinion
16 May 2023
REC opinion
Further Information Favourable Opinion